Center for Nanotechnology in Drug Delivery
The Center for Nanotechnology in Drug Delivery was established in June 2007 in the UNC Eshelman School of Pharmacy. CNDD’s efforts are aimed at improving health by enhancing the efficacy and safety of new drugs and imaging agents through the discovery and application of innovative methods of drug delivery.
The Center’s research focuses on safely and efficiently translating new therapeutic and imaging agents from bench to bedside with the goal of improving human health. CNDD serves to unify existing diverse technical and scientific expertise in biomedical and material science research at UNC through its world-class interdisciplinary drug delivery and nanomedicine program. The primary goal of the CNDD is to provide a foundation for synergistic research that translates into clinical benefits for diseases that currently have limited treatment options while simultaneously developing a critical and “visionary” area of science where the state of North Carolina is a world leader.
The key technologies employed by the Center include biomaterial sciences and engineering, polymer chemistry, nanotechnology and nanofabrication, pharmaceutical chemistry & formulation science, and nanotoxicology. The Center is a multi-disciplinary, multi-departmental entity, involving faculty members from different departments at UNC.
Conferences, Workshops, Seminars and Training
CNDD contributes to the national and international visibility and reputation of UNC and the Eshelman School of Pharmacy in the field of nanotechnology in drug delivery. We are proud to sponsor conferences, workshops and seminars that share knowledge about the latest research and advances in nanotechnologies in drug delivery.
The Center has organized scientific meetings including the annual Nanomedicine and Drug Delivery Symposium (NanoDDS) held in Chapel Hill. Our last NanoDDS attracted 275 participants from 11 countries.
Carolina Nanoformulation Workshop
The Carolina Nanoformulation Workshop focuses on both academic and industrial trainees and was first held in March 2016 in Chapel Hill, NC.
Dr. Gabriel Lopez-Berestein, Department of Experimental Therapeutics, Division of Cancer Medicine, MD Anderson Cancer CenterMarch 29, 2018
Dr. Michelle S. Bradbury, Director of Intraoperative Imaging, Radiology, Memorial Sloan Kettering Cancer CenterApril 12, 2018
The Distinguished Speaker, Jan E. Schnitzer, M.D.
Thursday, Oct. 12, 2017 at 9:30 a.m. in Marsico Hall, Room 4004
The Distinguished Speaker, Paula Hammond, Ph.D.
“Functional Modular Nanomaterials for Strategic Delivery of Combination Therapies”
Thursday, March 23, 2017 at 12:30-1:30 p.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Lily Yang, M.D., Ph.D.
“Theranostic Nanoparticles for Precision Oncology”
Thursday, Nov. 10, 2016 at 9:30 a.m.
The Distinguished Speaker, Justin Hanes, Ph.D.
The Distinguished Speaker, Gregory Lanza, M.D., Ph.D.
“Contact-Facilitated Drug Delivery of Lipase-Labile Prodrugs with Targeted Lipid-based Nanotherapies”
Wednesday, April 20, 2016 at 1:00 p.m. in Kerr Hall, Room 2001
The Distinguished Speaker, Stanislav Emelianov, Ph.D.
“Clinical translation of photoacoustic imaging: challenges and opportunities”
Thursday, Feb. 24, 2016 at 1:00 p.m. in Kerr Hall, Room 2001
The Distinguished Speaker, Francis C. Szoka, Ph.D.
“Investigations into Long Circulation and Tumor Penetration of NanoDrug Carriers”
Wednesday, Nov. 18, 2015 at 9:00 a.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Alexei A. Bogdanov, Ph.D.
“Molecular Imaging of Vascular Wall Inflammation”
Wednesday, Oct. 14, 2015 at 10:00 a.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Chad A. Mirkin, Ph.D.
“Liposomal Spherical Nucleic Acids: A New Approach to Immunomodulatory Therapies”
Wednesday, May 20, 2015 at 10:00 a.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Theresa M. Reineke, Ph.D.
“Sugar-Coated Complexes: Designed Polymers for Drug and Nucleic Acid Delivery”
Friday, May 8, 2015 at 10:00 a.m. in Beard Hall, Room 116
The Distinguished Speaker, Jeffrey A. Hubbell, Ph.D.
“Materials and Protein Engineering for Modulating Immunity and Tolerance”
Friday, May 1, 2015 at 10:00 a.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Dan Peer, Ph.D.
“Harnessing RNAi-Based Nanomedicines for Precision Therapy”
Friday, Jan. 30, 2015 at 12:00 p.m. in Marsico Hall, Room 2004
The Distinguished Speaker, Kazunori Kataoka, Ph.D.
“Block Copolymer Micelles as Smart Nanocarriers for Targeted Drug Delivery”
Friday, April 25, 2014 at 12:30 p.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Carlos Rinaldi, Ph.D.
“Magnetic Nanoparticles as Nanoscale Probes and Actuators in Complex Fluids and Biological Systems”
Tuesday, Sept. 10, 2013 at 1:30 p.m. in Kerr Hall, Room 1001
The Distinguished Speaker, Judy Riffle, Ph.D.
“Core-Shell Nanoparticles for Dual Drug Delivery and Bio-imaging”
Thursday, Feb. 6, 2013 at 1 p.m. in Beard Hall, Room 116
The Distinguished Speaker, Victor Kotelianski, M.D., Ph.D., D.Sc.
“In Vivo RNAi and Liver Functional Genomics”
Wednesday, Jan. 16, 2013 at 3:00 p.m. in Kerr Hall, Room 2001
T32 Postdoctoral Training Program
CNDD has developed an innovative postdoctoral training program in cancer nanotechnology and a unique training program. This 24 to 36 month National Cancer Institute–sponsored T32 postdoctoral training program’s goal is to equip a cohort of outstanding young scientists with the multidisciplinary concepts and skills needed to improve cancer diagnosis and therapy based on concepts, tools and discoveries made in nanoscience and nanotechnology.
Find out more about the T32 Postdoctoral Training Program Find out more here.